Heart Disease Clinical Trials in Cleveland

Showing 141-160 of 254 trials

A Study of CLR325 in Chronic Stable Heart Failure Patients.

NCT02696967

The purpose of this study was to determine the safety and tolerability of CLR325 intravenous (i.v.) infusion in patients with stable heart failure to determine if further clinical development of the drug in this indication was warranted.

Chronic Stable Heart Failure

Novartis Pharmaceuticals26 participantsStarted May 2016

Chicago, Illinois, United States • St Louis, Missouri, United States • Cleveland, Ohio, United States +8 more locations

COMPLETED< 1 mile

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

NCT00632372

The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D device. These devices may be placed at the same time or separately (staged procedure) at the discretion of the investigator. A comparison will be made between the information gathered from the CRT-D system and the information gathered by the left atrial pressure sensor.

Heart Failure

Abbott Medical Devices8 participantsStarted Jan 2008

Los Angeles, California, United States • Los Angeles, California, United States • Boston, Massachusetts, United States +7 more locations

A Study of CLR325 in Chronic Stable Heart Failure Patients.

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

Heart Disease Trials in Other Cities

VITROS Immunodiagnostic Products NT-proBNP II

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure

The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure

EVOLVE Short DAPT Study

Mitroflow DL Post Approval Study- North America

A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines

HW006 LATERAL Thoracotomy

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

HBP Device EGM Data Collection

Correlation of SOZO BIS Measures With CardioMEMS PA Pressure

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

SynCardia 70cc TAH-t for Destination Therapy (DT)

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

e-NOBORI Observational Registry of Nobori DES

Other Conditions in Cleveland